Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide

Tobias Traupe1, Philipp C Nett, Beat Frank

  • 1Department of Medicine, Internal Medicine I, Medical Policlinic, University Hospital Zurich, Switzerland.

Insights

Vascular function is impaired in prediabetic mice even before high blood sugar develops, linked to early inflammation involving inducible nitric oxide synthase (iNOS). This dysfunction affects blood vessel reactivity and cardiovascular risk in type 1 diabetes.

Area of Science:

  • Cardiovascular Physiology
  • Immunology
  • Endocrinology

Background:

  • Type 1 diabetes is an immuno-inflammatory condition associated with increased cardiovascular disease risk, especially in young adults.
  • Vascular dysfunction is a key contributor to cardiovascular complications in diabetes.

Purpose of the Study:

  • To investigate alterations in vascular function in non-obese diabetic (NOD) mice, a model prone to autoimmune diabetes.
  • To determine the involvement of the nitric oxide (NO)-cyclic GMP pathway in early vascular changes.

Main Methods:

  • Assessment of aortic ring relaxation in response to acetylcholine in prediabetic and diabetic NOD mice.
  • Inhibition of nitric oxide synthase (NOS) isoforms and guanylate cyclase using specific agents (1400W, L-NAME, ODQ).
  • Evaluation of contractile responses to endothelin-1 and big endothelin-1, alongside histological and immunohistochemical analyses.

Main Results:

  • Endothelium-dependent relaxation was significantly reduced in prediabetic NOD mice, preceding hyperglycemia.
  • Inhibition of inducible NOS (iNOS) with 1400W further impaired vascular responses in prediabetic mice.
  • Both endothelium-dependent and -independent vascular functions were abnormal in prediabetic NOD mice without structural damage.

Conclusions:

  • Vascular dysfunction in NOD mice occurs early in the prediabetic phase, independent of overt hyperglycemia or structural injury.
  • Early proinflammatory activation, particularly via iNOS, contributes to impaired vasoreactivity in diabetes-prone mice.
  • These findings highlight the critical role of early vascular changes and inflammation in the pathogenesis of diabetic cardiovascular complications.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...